Fortress Biotech Company Executives
| FBIOP Preferred Stock | USD 5.27 0.12 2.33% |
Fortress Biotech employs about 173 people. The company is managed by 7 executives with a total tenure of roughly 29 years, averaging almost 4.0 years of service per executive, having 24.71 employees per reported executive. Discussion of Fortress Biotech's management performance can provide insight into the enterprise performance.
| Lindsay Rosenwald Chairman Chairman of the Board and Presidentident, CEO |
| George Avgerinos President Senior Vice President - Biologics Operations |
Fortress |
Fortress Biotech's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Fortress Biotech's future performance. Based on our forecasts, it is anticipated that Fortress will maintain a workforce of slightly above 1600000 employees by December 2024.Fortress Biotech Management Team Effectiveness
The company has return on total asset (ROA) of (0.3494) % which means that it has lost $0.3494 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.4338) %, meaning that it generated substantial loss on money invested by shareholders. Fortress Biotech's management efficiency ratios could be used to measure how well Fortress Biotech manages its routine affairs as well as how well it operates its assets and liabilities.Fortress Biotech Workforce Comparison
Fortress Biotech Pref is rated # 4 in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 992. Fortress Biotech retains roughly 173 in number of employees claiming about 17% of equities under Health Care industry.
The company has Profit Margin (PM) of (1.17) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.63) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.63. Fortress Biotech Pref Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Fortress Biotech Pref Price Series Summation is a cross summation of Fortress Biotech price series and its benchmark/peer.
Fortress Biotech Notable Stakeholders
A Fortress Biotech stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Fortress Biotech often face trade-offs trying to please all of them. Fortress Biotech's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Fortress Biotech's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Lindsay Rosenwald | Chairman of the Board and Presidentident, CEO | Profile | |
| George Avgerinos | Senior Vice President - Biologics Operations | Profile | |
| Samuel Berry | Gen Sec | Profile | |
| Robyn Hunter | Ex Officer | Profile | |
| Michael Esq | Vice Devel | Profile | |
| Thomas Schaible | Project Disease | Profile | |
| David Jin | CFO Devel | Profile |
About Fortress Biotech Management Performance
The success or failure of an entity such as Fortress Biotech Pref often depends on how effective the management is. Fortress Biotech management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Fortress management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Fortress management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. Fortress Biotech, Inc. was incorporated in 2006 and is based in Bay Harbor Island, New York. Fortress Biotech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 173 people.
Fortress Biotech Workforce Analysis
Traditionally, organizations such as Fortress Biotech use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Fortress Biotech within its industry.Fortress Biotech Manpower Efficiency
Return on Fortress Biotech Manpower
| Revenue Per Employee | 397.6K | |
| Revenue Per Executive | 9.8M | |
| Net Loss Per Employee | 952.8K | |
| Net Loss Per Executive | 23.5M |
Additional Tools for Fortress Preferred Stock Analysis
When running Fortress Biotech's price analysis, check to measure Fortress Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fortress Biotech is operating at the current time. Most of Fortress Biotech's value examination focuses on studying past and present price action to predict the probability of Fortress Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fortress Biotech's price. Additionally, you may evaluate how the addition of Fortress Biotech to your portfolios can decrease your overall portfolio volatility.